+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Innovations and Growth Opportunities in Nebulizers, Bionic Devices, and AI Enabled Medical Platforms

  • PDF Icon

    Report

  • 67 Pages
  • September 2022
  • Region: Global
  • Frost & Sullivan
  • ID: 5740365

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical device and imaging industry. The issue includes advanced technologies in nebulization and inhalational drug delivery. Novel bionic devices and digital health solutions such as AI in imaging analysis, clinical decision making are also included in this issue. These innovations portray the diversity in their technology readiness levels, indicating an immediate or potential market impact. The growth opportunities for all these advanced medical device technologies are also covered in this issue.

The Advanced MedTech TOE analyzes and reports new and emerging technologies; advances in R&D, product development and regulatory matters specifically related to the areas of wearables, implantable, diagnostics, surgical tools and instrumentation, image guided surgery, drug delivery, patient monitoring, digital health, and medical imaging. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms. Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms.

Medical devices and imaging technology and innovation research covers cutting-edge global developments in medical devices and imaging sectors such as biosensors, biomaterials, biomechanics, microtechnologies, nanotechnologies, assistive technologies, and imaging technologies and platforms.

Table of Contents

1. Innovations in Medical Devices and Imaging

  • Mesh Nebulizer for Customizable Drug-device Combination
  • HCmed Innovations Co., Ltd. - Value Proposition
  • HCmed Innovations Co., Ltd. - Investor Dashboard
  • Portable Electronic Nebulizer for Treatment of Respiratory Diseases in Children
  • Norditalia Group S.r.l. - Value Proposition
  • Norditalia Group S.r.l. - Investor Dashboard
  • Voice-based Digital App to Monitor Lung Fluid in Patients with Congestive Heart Failure (CHF)
  • Cordio’s Value Proposition
  • Cordio - Investor Dashboard
  • Machine-learning Algorithm Technology for Monitoring Attention-deficit/Hyperactivity Disorder (ADHD) in Children
  • Iluria’s Value Proposition
  • Iluria - Investor Dashboard
  • AI-based Platform to Support Physicians' Clinical Decisions
  • Kahun’s Value Proposition
  • Kahun - Investor Dashboard
  • AI-powered Clinical Assistant to Support Doctors in Cardiovascular Disease Diagnosis and Treatment
  • Powerful Medical’s Value Proposition
  • Powerful Medical - Investor Dashboard
  • Artificial Intelligence (AI)-based Cardiac Magnetic Resonance Imaging
  • AI4MedImaging - Value Proposition
  • AI4MedImaging - Investor Dashboard
  • Ventricular Restoration System Enabling Transcatheter Treatment
  • Ancora Heart - Value Proposition
  • Ancora Heart - Investor Dashboard
  • Customized Nebulizer System for Amikacin Drug Delivery
  • PARI Pharma - Value Proposition
  • PARI Pharma - Investor Dashboard
  • Portable Orientation-agnostic Inhalation Drug Delivery Device
  • Qnovia - Value Proposition
  • Qnovia - Investor Dashboard
  • AI-based Embryo Quality Assessment Assistant for In Vitro Fertilization
  • Fairtility - Value Proposition
  • Fairtility - Investor Dashboard
  • AI-enabled Rapid Stroke Severity Assessment Tool
  • Avicenna.AI - Value Proposition
  • Avicenna.AI - Investor Dashboard
  • Bionic Hand with Customizable Grip Patterns for Below-the-elbow Amputees
  • Aether Biomedical Sp. z o.o. - Value Proposition
  • Aether Biomedical Sp. z o.o. - Investor Dashboard
  • Bionic Knee for Patients with Above-knee Amputation
  • Reboocon Bionic - Value Proposition
  • Reboocon Bionics - Investor Dashboard
  • Blood Filtration System for Removing Harmful Viruses and Exosomes
  • Aethlon - Value Proposition
  • Aethlon - Investor Dashboard
  • Connected Nebulizer for Improving Medication Adherence
  • AireHealth - Value Proposition
  • AireHealth - Investor Dashboard
  • Use of Personalized Approach for Aerosol Drug Delivery
  • Monash University - Value Proposition
  • Visual Suprachoroidal Prosthesis System for Providing Artificial Vision
  • University of Sydney - Value Proposition

2. Key Contacts

3. Appendix

  • Criteria for Rating of Innovations - Explanation

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aether Biomedical Sp. z o.o.
  • Aethlon
  • AI4MedImaging
  • AireHealth
  • Ancora Heart
  • Avicenna.AI
  • Cordio
  • Fairtility
  • HCmed Innovations Co. Ltd.
  • Iluria
  • Kahun
  • Norditalia Group S.r.l.
  • PARI Pharma
  • Powerful Medical
  • Qnovia
  • Reboocon Bionics